The burden of short bowel syndrome (SBS) on patients, caregivers and family members is substantial. By understanding the transition process from pediatric to adult care, how to adjust, adhere to the treatment plan, and make informed decisions about managing SBS, patients and caregivers can be more involved with their health care team to ensure a smooth and complete transition of uninterrupted care.
This interactive guide provides guidance to pediatric and adult health care professionals to better manage the transition of care for pediatric and adolescent patients with short bowel syndrome. The guide encourages health care professionals to engage parents and youth with education about their role in the transition process and how the health care environment changes and the difference between pediatric and adult care.
View Guide
Features
Interactive, web-based guide that can be downloaded and printed. Includes dynamic, printable and customizable documents to be used by health care professional office staff and shared with patients to connect learning to life behaviors. Printable materials include transition policy, progress tracking, transition planning and readiness, transfer of care, and follow up evaluation.
Faculty
Valeria C. Cohran, MD, Ann & Robert H. Lurie Children's Hospital of Chicago, Illinois
Rajeev Jain, MD, AGAF, Texas Digestive Disease Consultants, Dallas
Elizabeth Wall, MS, RDN-AP, The University of Chicago Medical Center Illinois
Learning Objectives:
- Identify short bowel syndrome patients at the appropriate age range to initiate the transition plan.
- Emphasize the importance of coordination of care and implementation of a transition plan.
- Encourage engagement and shared responsibility between patients and their health care providers in their individualized short bowel syndrome treatment and transition from pediatric to adult care.
- Integrate recommendations to help short bowel syndrome patients and caregivers understand the transition process.
- Empower SBS patients and caregivers to become more engaged and learn how to utilize transition-planning tools.
Disclosures
Valeria Cohran, MD, Abbott Nutrition, Consulting Fee, Speaking/Teaching; Nutricia, Consulting Fee, Consulting
Elizabeth Wall, MS, RDN-AP, Zealand Pharma, Consulting Fee, Advisory Committee/Review Panel; Baxter, Consulting Fee, Advisory Committee/Review Panel; Takeda, Consulting Fee, Advisory Committee/Review Panel
Rajeev Jain, MD, AGAF,
Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: Apr.22, 2024
